Alpha Wolf Capital : Strong start for December

Good morning folks,
We had a nice move in the markets yesterday with small float China plays being the flavor of the day. These stocks are ideal day trading opportunities if you can catch them in the early stage of their breakout.
The SMH continues to climb and the IBB started out the day weak but managed to claw its way back to green by end of day. In my opinion we need the IBB to break out if we want to see new highs in the overall markets. The IWM is still struggling with that resistance we talked about in the market wrap video.
It was a nice start to a new month lets see if we can continue the move all the way into the end of the year.
We get some Fed news today with the Biege book out at 2 eastern time and we have Yellen testifying before congress tomorrow so the market could go into a stalling pattern. I wouldn't be shocked if we had some choppy action over the next couple of days.
A few spec names to watch CJJD YECO KOOL DCTH

Stocks on my radar premarket

Bullish and may have a swing or lottos in play

Cautiously optimistic

Very Cautious may even present a short opportunity ..

07:52:53am
12/02/15

QCOM

Qaulcomm +3.37% Premarket @$50.96; Qualcomm, Xiaomi Sign 3G/4G License Agreement

This is more of a swing or long term hold type stock the daily is UGLY, however it may be time to start nibbling and building a position for a value play if it can reclaim 50 with authority

06:32:37am
12/02/15

AFFX

Affymetrix and Reveal Biosciences Partner to Offer RNA ISH Tissue Staining, Imaging, and Image Analysis Services

looking for a test and roll of the 10 dolla holla decent balance sheet could be more of a swing

12/02/15

POWR

PowerSecure Acquires ESCO Energy Services Company, ~$1.8M In Cash And Promissory Notes, ESCO May Receive Earn-Out Pmts Until 2018

typically the acquiring company pulls back daily has a nice look small float it ran into this news on watch over the next few days for either a break out to the 15 dolla holla or a pullback to support around 13

PDL BioPharma acknowledges receipt of $133.7 mln in notable cash payments from November 1-December 1 (PDLI) :

The payments include the following:

$14.0 million royalty payment received from Biogen, Inc. for royalties due from the Queen et al. patent license.
$104.9 million royalty payment received from Genentech, Inc. for royalties due from the Queen et al. patent license.
$5.3 million royalty payment for Glumetza for the month of October received from Valeant Pharmaceuticals International
$9.5 million payment from Accel 300, LLC, a wholly-owned subsidiary of kalo, Inc. for note payments, which included $4.6 million in principal and $4.9 million in interest payment due.

Looking for a potential double bottom ugly down trend on the daily potential day trade opp